Anavo Therapeutics extends Seed Round to EUR 28 Million to A

Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase biology, announced today an EUR 8.5 million seed round extension, adding MRL Ventures Fund as a

Related Keywords

Germany , Japan , Netherlands , Cambridge , Cambridgeshire , United Kingdom , Liechtenstein , Israel , United States , Amsterdam , Noord Holland , Japanese , Karin Kleinhans , Birgit Zech , Debora Dumont , Simone Botti , Sakae Asanuma , Charles Mcdermott , Bioqube Factory Fund , Taiho Ventures , Ventures Fund , Taiho Pharmaceutical Co Ltd , Merck Kga , Merck Co Inc , Merck Kgaa , Anavo Therapeutics , Bioqube Ventures , Chief Executive Officer , Therese Maria Liechtenstein , Executive Officer , Anavo , Herapeutics , Xtends , Need , Hound , Billion , Advance , Pipeline , Novel , Phosphatase , Modulators , Howard , Clinic ,